Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein
Open Access
- 1 August 2002
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 22 (15) , 5319-5336
- https://doi.org/10.1128/mcb.22.15.5319-5336.2002
Abstract
It is becoming increasingly evident that the degradation of nuclear proteins requires nuclear-cytoplasmic trafficking of both the substrate proteins, as well as the E3 ubiquitin-ligases. Here, we show that nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein (VHL) is required for oxygen-dependent ubiquitination and degradation of the alpha subunits of hypoxia-inducible factor (HIF-α). VHL engages in a constitutive transcription-sensitive nuclear-cytoplasmic shuttle unaffected by oxygen tension or levels of nuclear substrate HIF-α. Ubiquitinated forms of HIF-α, as well as VHL/ubiquitinated HIF-α complexes, are found solely in the nuclear compartment of normoxic or reoxygenated VHL-competent cells. HIF-α localizes exclusively in the nucleus of hypoxic cells but is exported to the cytoplasm upon reoxygenation. Oxygen-dependent nuclear ubiquitination and nuclear export of HIF-α can be prevented by treatment with an HIF-specific prolyl hydroxylase inhibitor. Treatment with inhibitors of RNA polymerase II activity, which interfere with the ability of VHL to engage in nuclear export, also prevents cytoplasmic accumulation of HIF-α in reoxygenated cells. This caused a marked increase in the HIF-α half-life without affecting its nuclear ubiquitination. We present a model by which VHL-mediated ubiquitination of HIF-α and its subsequent degradation are dependent upon dynamic nuclear-cytoplasmic trafficking of both the E3 ubiquitin-ligase and the nuclear substrate protein.Keywords
This publication has 73 references indexed in Scilit:
- Cocompartmentalization of p53 and Mdm2 Is a Major Determinant for Mdm2-Mediated Degradation of p53Experimental Cell Research, 2001
- Expression and Characterization of Hypoxia-Inducible Factor (HIF)-3α in Human Kidney: Suppression of HIF-Mediated Gene Expression by HIF-3αBiochemical and Biophysical Research Communications, 2001
- Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylationThe EMBO Journal, 2001
- Perivenous expression of the mRNA of the three hypoxia-inducible factor α-subunits, HIF1α, HIF2α and HIF3α, in rat liverBiochemical Journal, 2001
- HIF‐1‐dependent transcriptional activity is required for oxygen‐mediated HIF‐1α degradationFEBS Letters, 2001
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Ran-mediated Nuclear Export of the von Hippel-Lindau Tumor Suppressor Protein Occurs Independently of Its Assembly with Cullin-2Published by Elsevier ,2000
- Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activityOncogene, 1999
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993